Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Sleep and affective disorders in relation to Parkinson's disease risk among older women from the Women's Health Initiative.

Authors:
Hind A Beydoun Jiu-Chiuan Chen Nazmus Saquib Michelle J Naughton May A Beydoun Aladdin H Shadyab Lauren Hale Alan B Zonderman

J Affect Disord 2022 09 22;312:177-187. Epub 2022 Jun 22.

Laboratory of Epidemiology and Population Sciences, National Institute on Aging, NIA/NIH/IRP, Baltimore, MD 21225, USA.

Objectives: To evaluate sleep and affective (mood/anxiety) disorders as clinical predictors of incident Parkinson's disease (PD) among women ≥65 years of age.

Methods: We performed secondary analyses with available data from the Women's Health Initiative Clinical Trials and Observational Study linked to Medicare claims. Sleep, mood and anxiety disorders at baseline were defined using diagnostic codes. Incident PD was defined using self-reported PD, first PD diagnosis, use of PD medications, and/or deaths attributed to PD. Cox regression was applied to estimate hazard ratios (HR) with 95 % confidence intervals (CI), controlling for socio-demographic/lifestyle/health characteristics. Time-to-event was calculated from baseline (1993-1998) to year of PD event, loss to follow-up, death, or December 31, 2018, whichever came first.

Results: A total of 53,996 study-eligible WHI participants yielded 1756 (3.25 %) PD cases over ~14.39 (±6.18) years of follow-up. The relative risk for PD doubled among women with affective disorders (HR = 2.05, 95 % CI: 1.84, 2.27), mood disorders (HR = 2.18, 95 % CI: 1.97, 2.42) and anxiety disorders (HR = 1.97, 95 % CI: 1.75, 2.22). Sleep disorders alone (without affective) were not significantly associated with PD risk (HR = 0.85, 95 % CI: 0.69, 1.04), whereas affective disorders alone (without sleep) (HR = 1.93, 95 % CI: 1.72, 2.17) or in combination with sleep disorders (HR = 2.18, 95 % CI: 1.85, 2.56) were associated with twice the PD risk relative to no sleep/affective disorders.

Limitations: Observational design; Selection bias; Information bias; Generalizability.

Conclusions: Among older women, joint sleep/affective disorders and affective disorders alone are strong clinical predictors of incident PD over 14 years.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2022.06.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302785PMC
September 2022

Publication Analysis

Top Keywords

affective disorders
16
disorders
11
women's health
8
sleep affective
8
anxiety disorders
8
disorders hr = 218
8
hr = 218 95 %
8
sleep disorders
8
parkinson's disease
8
disorders affective
8
associated risk
8
predictors incident
8
clinical predictors
8
health initiative
8
older women
8
95 %
7
sleep
6
affective
5
disorders strong
4
total 53996
4

Keyword Occurance

Similar Publications

Pre-existing Mental Health Diagnoses Are Associated with Higher Rates of Postoperative Complications, Readmissions, and Reoperations Following Arthroscopic Rotator Cuff Repair.

Authors:
Ryan Freshman Jacob F Oeding Christopher Anigwe Alan Zhang Brian Feeley C Benjamin Ma Drew A Lansdown

Arthroscopy 2022 Aug 12. Epub 2022 Aug 12.

UCSF Department of Orthopedic Surgery, San Francisco, CA.

Purpose: To investigate the association between pre-operative mental health disorders and post-operative complications, readmissions, and ipsilateral revision procedures amongst patients undergoing arthroscopic rotator cuff repair (RCR).

Methods: A retrospective cohort study from 2010 to 2020 was performed using the PearlDiver database. Current Procedural Terminology (CPT) and International Classification of Diseases (ICD) codes were used to compare patients with and without mental health disorders who underwent arthroscopic RCR. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Efficacy of adjunctive brexpiprazole on symptom clusters of major depressive disorder: A post hoc analysis of four clinical studies.

Authors:
Martin A Katzman François Therrien Erin M MacKenzie Fan Wang Anne de Jong-Laird Matthieu Boucher

J Affect Disord 2022 Aug 12. Epub 2022 Aug 12.

Otsuka Canada Pharmaceutical Inc., Saint-Laurent, QC, Canada; Department of Pharmacology & Therapeutics, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.

Background: Major depressive disorder (MDD) is a clinically heterogenous condition and its treatment should be individualized according to the presence of particular symptom clusters. The aim of this pooled analysis was to investigate the effects of adjunctive brexpiprazole on different symptom clusters in MDD.

Methods: Data were included from four similarly designed, short-term, randomized, double-blind, placebo-controlled studies of adjunctive brexpiprazole in adults with MDD and inadequate response to 2-4 antidepressant treatments (ADTs), including 1 administered by investigators. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Cognitive impairment, childhood trauma, sedentary behaviour, and elevated C-reactive protein levels in major affective disorders.

Authors:
Ana Carolina Congio Mariana Ragassi Urbano Maria Rita Zoega Soares Sandra Odebrecht Vargas Nunes

J Psychiatr Res 2022 Jul 31;155:1-9. Epub 2022 Jul 31.

Health Sciences Postgraduate Program, Health Sciences Center, State University of Londrina (UEL), Londrina, Paraná, Brazil; Department of Clinical Medicine, Psychiatry Unit, Health Sciences Center, State University of Londrina, (UEL), Londrina, Paraná, Brazil.

Elevated C-reactive protein (CRP) levels were associated with cognitive decline, sedentary behaviour, and childhood trauma in patients with major affective disorders. This study aims to examine the association of peripheral CRP levels, cognitive function, childhood trauma, sedentary behaviour, and quality of life in individuals with major affective disorders, including bipolar disorder (BD), major depressive disorder (MDD), and individuals without mood disorders (controls). We included outpatients with BD (n = 42), MDD (n = 27), and healthy controls (n = 40). Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Adapting integrative cognitive-affective therapy for adolescents with full and subthreshold bulimia nervosa: A feasibility study.

Authors:
Jocelyn Lebow Leslie Sim Stephen Wonderlich Carol B Peterson

Eur Eat Disord Rev 2022 Aug 15. Epub 2022 Aug 15.

Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis, Minnesota, USA.

Background: Integrative Cognitive Affective Therapy (ICAT) is an empirically supported treatment for bulimia nervosa (BN) in adults. However, it is unclear whether a modified version, Integrative Cognitive Affective Therapy-Adolescent (ICAT-A) is feasible and beneficial for adolescents. This study evaluated the feasibility of ICAT-A for adolescents with BN or subthreshold BN. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Clinical Targets and Attitudes Toward Implementing Digital Health Tools for Remote Measurement in Treatment for Depression: Focus Groups With Patients and Clinicians.

Authors:
Valeria de Angel Serena Lewis Katie M White Faith Matcham Matthew Hotopf

JMIR Ment Health 2022 Aug 15;9(8):e38934. Epub 2022 Aug 15.

Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Background: Remote measurement technologies, such as smartphones and wearable devices, can improve treatment outcomes for depression through enhanced illness characterization and monitoring. However, little is known about digital outcomes that are clinically meaningful to patients and clinicians. Moreover, if these technologies are to be successfully implemented within treatment, stakeholders' views on the barriers to and facilitators of their implementation in treatment must be considered. Read More

View Article and Full-Text PDF
August 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap